DAA2033 |
Alterations in structural proteins and cell membranes in the lenses |
Physiological |
lens |
Human |
— |
— |
|
DAA2041 |
Altered brain mitochondrial metabolism |
Physiological |
brain |
Human |
— |
— |
|
DAA2054 |
Altered cardiovascular response during heating |
Physiological |
cardiovascular system |
Human |
— |
— |
|
DAA2031 |
Altered concentration of sodium, potassium and calcium |
Physiological |
lens |
Human |
— |
— |
|
DAA748 |
Altered sleep parameters and patterns |
Psychological |
brain |
Human |
— |
— |
|
DAA815 |
Alveolar duct size increases |
Physiological |
alveolus |
Human |
— |
— |
|
DAA797 |
Alveoli's ability decreases |
Physiological |
alveolus |
Human |
— |
— |
|
DAA615 |
Alzheimer's disease |
Pathological |
brain |
Human |
— |
SeriesMorbidity |
|
DAA1696 |
amiloride-sensitive cation channel 1, neuronal (degenerin) |
Molecular |
lung |
Mouse |
Accn1 |
57.0% Increase Gene Expression Level |
|
DAA347 |
aminolevulinate, delta-, synthase 1 |
Molecular |
skeletal muscle |
Human |
ALAS1 |
4.0% Decrease Gene Expression Level |
|
DAA1567 |
AMME chromosomal region gene 1-like |
Molecular |
lung |
Mouse |
Ammecr1l |
2.0% Decrease Gene Expression Level |
|
DAA2394 |
AMP-activated protein kinase; non-catalytic gamma-3 subunit decreases with age |
Molecular |
dermis |
Human |
PRKAG3 |
17.8% Decrease DNA Methylation |
|
DAA2444 |
AMP-activated protein kinase; non-catalytic gamma-3 subunit decreases with age |
Molecular |
mesenchymal stem cell |
Human |
PRKAG3 |
20.1% Decrease DNA Methylation |
|
DAA2443 |
AMP-activated protein kinase; non-catalytic gamma-3 subunit decreases with age |
Molecular |
mesenchymal stem cell |
Human |
PRKAG3 |
15.1% Decrease DNA Methylation |
|
DAA2395 |
AMP-activated protein kinase; non-catalytic gamma-3 subunit decreases with age |
Molecular |
dermis |
Human |
PRKAG3 |
20.1% Decrease DNA Methylation |
|
DAA1722 |
amylase 1, salivary |
Molecular |
muscle |
Mouse |
Amy1 |
12.0% Increase Gene Expression Level |
|
DAA267 |
amyloid beta (A4) precursor protein-binding, family B, member 1 interacting protein |
Molecular |
kidney |
Human |
APBB1IP |
23.0% Increase Gene Expression Level |
|
DAA2100 |
anaphase promoting complex subunit 4 decreases with age |
Molecular |
ovary |
Human |
ANAPC4 |
35.5% Decrease Gene Expression Level |
|
DAA612 |
Anemia |
Pathological |
blood |
Human |
— |
SeriesMorbidity |
|
DAA2119 |
angel homolog 2 (Drosophila) decreases with age |
Molecular |
ovary |
Human |
ANGEL2 |
65.3% Decrease Gene Expression Level |
|
DAA8 |
angiomotin |
Molecular |
brain |
Human |
AMOT |
10.0% Increase Gene Expression Level |
|
DAA1723 |
angiopoietin 1 |
Molecular |
muscle |
Mouse |
Angpt1 |
16.0% Decrease Gene Expression Level |
|
DAA9 |
ankyrin 2, neuronal |
Molecular |
brain |
Human |
ANK2 |
20.0% Decrease Gene Expression Level |
|
DAA1610 |
ankyrin repeat domain 26 |
Molecular |
lung |
Mouse |
Ankrd26 |
3.0% Decrease Gene Expression Level |
|
DAA1394 |
annexin A2 |
Molecular |
hippocampus |
Mouse |
Anxa2 |
8.0% Increase Gene Expression Level |
|